RJA
INCY icon

Ross\Johnson & Associates’s Incyte INCY Stock Holding History

Ross\Johnson & Associates’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$848 – 278
2025
Q1 		$848 Buy
+14
New +$976 0.01% 219

Other funds holding INCY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ross\Johnson & Associates's INCY Position: Q2 2025 in Review

Ross\Johnson & Associates sold out of Incyte (INCY) in Q2 2025, closing a stake of 14 shares — an estimated $848 sold.

Ross\Johnson & Associates first reported a position in INCY in Q1 2025 and held it in 1 quarter. The position peaked at $848 in Q1 2025. 657 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Ross\Johnson & Associates reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Ross\Johnson & Associates sold 14 Incyte shares in Q2 2025, an estimated $848.
  • Ross\Johnson & Associates first reported a position in Incyte in Q1 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Incyte position peaked at $848 in Q1 2025.
  • 657 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Ross\Johnson & Associates's 13F filing for Q2 2025, filed 15 Aug 2025.